Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission in which antibodies are directed against voltage-gated calcium channels (VGCCs). We studied the action of LEMS immunoglobulin G (IgG) on cloned human VGCCs stably transfected into human embryonic kidney...
Κύριοι συγγραφείς: | Lang, B, Pinto, A, Giovannini, F, Newsom-Davis, J, Vincent, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2003
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
ανά: Bain, P, κ.ά.
Έκδοση: (1996) -
Autoantibodies in the Lambert-Eaton myasthenic syndrome (LEMS) and amyotrophic lateral sclerosis (ALS)
ανά: Lang, B
Έκδοση: (2007) -
Autoantibodies in the Lambert-Eaton Myasthenic Syndrome (LEMS) and Amyotrophic Lateral Sclerosis (ALS)
ανά: Lang, B, κ.ά.
Έκδοση: (2013) -
Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
ανά: Motomura, M, κ.ά.
Έκδοση: (1997) -
Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.
ανά: Maddison, P, κ.ά.
Έκδοση: (2001)